Repository logo
 

Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian Cells.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Stephens, Amberley D  ORCID logo  https://orcid.org/0000-0002-7303-6392
Lu, Meng 
Fernandez-Villegas, Ana 
Kaminski Schierle, Gabriele S  ORCID logo  https://orcid.org/0000-0002-1843-2202

Abstract

The Alzheimer's disease related peptide, Amyloid-beta (Aβ)1-40 and 1-42, has proven difficult to be purified as a recombinant monomeric protein due its expression in E. coli leading to the formation of insoluble inclusion bodies and its tendency to quickly form insoluble aggregates. A vast array of methods have been used so far, yet many have pitfalls, such as the use of tags for ease of Aβ isolation, the formation of Aβ multimers within the time frame of extraction, or the need to reconstitute Aβ from a freeze-dried state. Here, we present a rapid protocol to produce highly pure and monomeric recombinant Aβ using a one-step ion exchange purification method and to label the peptide using a maleimide dye. The washing, solubilization, and purification steps take only 3 h. We also present a protocol for the isolation of Aβ-mCherry from mammalian cells.

Description

Keywords

Aβ40, Aβ42, E22G, amyloid, arctic mutant, dye labeling, fluorescence, inclusion bodies, ion exchange chromatography, mCherry, maleimide, Alzheimer Disease, Amyloid beta-Peptides, Animals, Escherichia coli, Peptide Fragments, Recombinant Proteins

Journal Title

ACS Chem Neurosci

Conference Name

Journal ISSN

1948-7193
1948-7193

Volume Title

11

Publisher

American Chemical Society (ACS)

Rights

All rights reserved
Sponsorship
Alzheimer's Research UK (ARUK-PG2013-14)
Medical Research Council (MR/K02292X/1)
Wellcome Trust (065807/Z/01/Z)
Wellcome Trust (203249/Z/16/Z)
Biotechnology and Biological Sciences Research Council (BB/H023917/1)
Medical Research Council (G0902243)
Wellcome Trust (065807/Z/01/Z) (203249/Z/16/Z), the UK Medical Research Council (MRC) (MR/K02292X/1), Alzheimer Research UK (ARUK) (ARUK-PG013-14), Michael J Fox Foundation (16238) and Infinitus China Ltd
Relationships
Is supplemented by: